Does Mounjaro Cause Erectile Dysfunction?

Step 1: Check what the licensed prescribing information records

The first practical thing anyone can do in under a minute: search "tirzepatide" on the Electronic Medicines Compendium, open the Mounjaro SmPC, and look at section 4.8 (undesirable effects). ED does not appear there. That absence is meaningful — Eli Lilly was required to report all adverse events that occurred at a higher rate in tirzepatide groups than in placebo groups across a large clinical programme.

The SURMOUNT-1 trial alone randomised 2,539 adults with obesity and ran for 72 weeks, with systematic safety reporting throughout. Across the broader SURMOUNT and SURPASS programmes (more than 10,000 participants in total) sexual dysfunction in men was not flagged as a treatment-emergent finding linked to the drug. That is a reasonable baseline for reassurance, even though no clinical trial captures every real-world experience.

What the trial did consistently show was a GI-led side-effect profile: nausea, diarrhoea, constipation, and indigestion are the commonest complaints, particularly in the weeks after starting or after a dose increase. You can read more about how the medicine works on our Mounjaro weight loss mechanism page.

Step 2: Understand why obesity and ED are already linked

Before attributing anything to the drug, it helps to understand the background. Erectile dysfunction is closely associated with obesity, cardiovascular disease and type 2 diabetes, the very conditions Mounjaro is most often used to treat. The mechanisms are fairly well characterised: excess adipose tissue raises oestrogen and lowers free testosterone; vascular inflammation impairs endothelial function; and insulin resistance affects smooth muscle responsiveness.

In short, many men asking whether Mounjaro can cause ED are already at elevated baseline risk of ED from their underlying health picture. If ED emerges after starting treatment, the honest answer is that timing does not establish causation. A prescriber needs to assess blood pressure, fasting glucose, cardiovascular markers and medication history before the cause can be narrowed down.

Our Mounjaro overview explains the broader clinical context for the medicine, including the conditions it is licensed alongside.

Step 3: Consider what weight loss itself does to sexual health

The picture here is generally positive for men with obesity. Peer-reviewed evidence suggests that clinically significant weight loss tends to improve testosterone levels, reduce sex-hormone-binding globulin, and improve vascular function, all of which support erectile health rather than undermining it. The SURMOUNT-1 participants who completed 72 weeks at 15mg lost an average of around 20–21% of body weight, a magnitude of change that carries meaningful physiological effects beyond the scales.

None of that means every man on Mounjaro will see improvement in sexual function, individual response varies, and other factors (stress, relationship dynamics, cardiovascular health, other medicines) matter considerably. But the broad direction of evidence does not support the idea that tirzepatide causes ED. If anything, the metabolic improvements associated with meaningful weight loss tend to move in the opposite direction.

It is also worth checking whether any other medicines you take are listed as having sexual side effects, antihypertensives, antidepressants, and some cholesterol-lowering agents all have documented effects in this area. A prescriber can review your full medication list. Curious about the cost side of private treatment? Our Mounjaro prices guide sets out what private treatment typically involves.

Step 4: When to raise it with your prescriber

If you are already on Mounjaro and have noticed changes to erectile function, the right move is a direct conversation with your prescriber, not stopping treatment without clinical guidance. The prescriber can review whether the timing correlates with a dose increase, whether GI side effects (dehydration, fatigue, disrupted sleep) might be temporarily affecting libido, and whether blood tests are warranted to look at testosterone or blood glucose. These are clinical questions, not embarrassing ones; our prescribers hear them regularly.

Mounjaro carries a Black Triangle (▼) designation, meaning the MHRA actively collects new safety data as it builds in the real-world population. If you genuinely believe you are experiencing a side effect not listed in the leaflet, reporting it via the MHRA Yellow Card scheme adds to that surveillance and helps future patients. Our FAQs cover how clinical review works at nume and what happens if you have concerns during treatment.

Some men also ask about other unexpected symptoms, questions like whether Mounjaro affects skin or whether it has any link to neurological symptoms are part of the same pattern of careful, reasonable curiosity. Men taking Mounjaro alongside mood-stabilising medication may also find it helpful to read about how Mounjaro interacts with bipolar disorder and its treatments before starting. The right answer is always the same: check the official prescribing information, raise it with your prescriber, and report anything genuinely unexpected through the Yellow Card. If you are yet to start treatment and want a clinical assessment, check your eligibility with our team.